Upcoming events

First-in-man studies in tricuspid intervention and myocardial protection

Session comprising selected EuroPCR 2017 CV Pipeline submissions

Chairpersons: C. Lotan, H. Treede

Summary

Consult this session on the First-in-man studies in tricuspid intervention and myocardial protection by P. Denti, T. Koyama, A. Lauten, M.B. Leon, J.L. Navia, L. Otterspoor and R. Schueler if you want to find out more about the MitraClip system, Caval Valve Implantation, novel transcatheter tricuspid valve and more.

Presentations available when logged in:

  • Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique
  • Pre-clinical experience with new percutaneous tricuspid valve repair system
  • Caval Valve Implantation (CAVI) as interventional treatment option for severe tricuspid regurgitation - results from the CAVI-TricValve-Registry
  • First-in-man experience of a novel TTVR in a patient with severe tricuspid valve regurgitation
  • Reinventing the heart valve: bioabsorbable valves enabling cardiovascular restoration
  • First-in-man application of selective intracoronary hypothermia in acute myocardial infarction. The SINTAMI trial
  • Cardioprotection using post-conditioning with lactate-enriched blood in STEMI patients